how often to use bpc 157 BPC-157 Peptide Therapy for Healing Gray market peptides blur drug

What can I do at this point?

What is the purpose of combining BPC-157 and TB-500 in a peptide blend

Considering the scarcity of human studies on the peptide and the fact that not all studies conducted on animals can always be freely transferred to humans, more extensive human-oriented studies indicating therapeutic and toxic proles of BPC 157 are required at once

Clinical studies have shown KPV's half-life ranges from 2-4 hours when administered subcutaneously, requiring daily dosing for sustained therapeutic effects

Brain sections from patients who died from COVID-19 showed fibrinogen extravasation and coagulation system dysregulation 21,22 , while mouse models revealed changes in blood vessel morphology with the appearance of string vessels, that is, pathological ghost vessels without endothelial cells 28